Triapine
- Generic Name
- Triapine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C7H9N5S
- CAS Number
- 143621-35-6
- Unique Ingredient Identifier
- U4XIL4091C
- Background
Triapine has been used in trials studying the treatment of Leukemia, Lung Cancer, Kidney Cancer, Prostate Cancer, and Pancreatic Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer
Phase 2
Completed
- Conditions
- Stage IVA Gallbladder CancerStage II Gallbladder CancerStage IIIA Gallbladder CancerStage IVB Gallbladder CancerStage IIIB Gallbladder Cancer
- Interventions
- First Posted Date
- 2004-01-12
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 33
- Registration Number
- NCT00075504
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath